FBInvestor
Stocks / Apellis Pharmaceuticals Inc
Institutional Ownership

Apellis Pharmaceuticals Inc

CUSIP 03753U106COMAPLSUSDQ1 2026

Institutional Holders
313
13F filers
Shares Held
128.97M
Aggregate institutional
Institutional Value
$5.02B
Q1 2026
Net New Holders
+41
116 new · 75 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions116
Increased91
Decreased70
Sold out75

Institutional Holders

313 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Blackrock, Inc.13.54M$544.59M+7.28MAdded
2Avoro Capital Advisors LLC12.22M$491.70M0Held
3Morgan Stanley10.04M$404.01M+869.4KAdded
4State Street Corp6.84M$275.37M+2.23MAdded
5Ubs Group AG6.21M$249.69M+2.02MAdded
6Pentwater Capital Management LP5.25M$211.21M+5.25MNew
7Deep Track Capital, LP4.53M$182.34M3.22MReduced
8Point72 Asset Management, L.P.4.18M$168.32M+3.59MAdded
9Rtw Investments, LP3.69M$148.25M3.98MReduced
10Hbk Investments L P3.55M$142.82M+3.55MNew

303 more institutional holders on Premium

See every fund holding Apellis Pharmaceuticals Inc, with full quarter-over-quarter share changes.

Unlock all holders